{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:29:12Z","timestamp":1790728152883,"version":"4.1.0"},"reference-count":96,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T00:00:00Z","timestamp":1570665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0222833","type":"journal-article","created":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T17:56:24Z","timestamp":1570730184000},"page":"e0222833","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":30,"title":["A novel fast-slow model of diabetes progression: Insights into mechanisms of response to the interventions in the Diabetes Prevention Program"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7712-056X","authenticated-orcid":true,"given":"Andrea","family":"De Gaetano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas Andrew","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,10,10]]},"reference":[{"key":"pone.0222833.ref001","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.apnum.2005.04.023","article-title":"Mathematical models and software tools for the glucose-insulin regulatory system and diabetes: An overview","volume":"56","author":"A Makroglou","year":"2006","journal-title":"Applied Numerical Mathematics"},{"key":"pone.0222833.ref002","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1038\/psp.2013.30","article-title":"The impact of mathematical modeling on the understanding of diabetes and related complications","volume":"2","author":"I Ajmera","year":"2013","journal-title":"CPT Pharmacometrics and Systems Pharmacology"},{"key":"pone.0222833.ref003","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.mbs.2013.05.006","article-title":"Mathematical modeling of the glucose\u2013insulin system: A review","volume":"244","author":"P Palumbo","year":"2013","journal-title":"Math Biosci"},{"key":"pone.0222833.ref004","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mbs.2014.09.003","article-title":"Model-based control of plasma glycemia: Tests on populations of virtual patients","volume":"257","author":"P Palumbo","year":"2014","journal-title":"Math Biosci"},{"key":"pone.0222833.ref005","doi-asserted-by":"crossref","first-page":"e0142344","DOI":"10.1371\/journal.pone.0142344","article-title":"A unifying organ model of pancreatic insulin secretion","volume":"10","author":"A De Gaetano","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"pone.0222833.ref006","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00285-015-0935-7","article-title":"A glycemia-structured population model","volume":"73","author":"A Borri","year":"2016","journal-title":"J Math Biol"},{"key":"pone.0222833.ref007","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1006\/jtbi.2000.2150","article-title":"A model of beta-cell mass, insulin, and glucose kinetics: pathways to diabetes","volume":"206","author":"BG Topp","year":"2000","journal-title":"J Theor Biol"},{"key":"pone.0222833.ref008","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2165\/00019053-200624001-00002","article-title":"A model of long-term metabolic progression of type 2 diabetes mellitus for evaluating treatment strategies","volume":"24S1","author":"A Bagust","year":"2006","journal-title":"PharmacoEconomics"},{"key":"pone.0222833.ref009","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s10928-006-9008-2","article-title":"A mechanism-based disease progression model for comparison of long-term effects of pioglitazone, metformin and gliclazide on disease processes underlying type 2 diabetes mellitus","volume":"33","author":"W de Winter","year":"2006","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"pone.0222833.ref010","first-page":"E1462","article-title":"Mathematical models of diabetes progression","volume":"295","author":"A De Gaetano","year":"2008","journal-title":"Am J Physiol"},{"key":"pone.0222833.ref011","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1177\/0091270009349711","article-title":"A model for glucose, insulin, and beta-cell dynamics in subjects with insulin resistance and patients with type 2 diabetes","volume":"50","author":"J Ribbing","year":"2010","journal-title":"J Clin Pharmacol"},{"key":"pone.0222833.ref012","doi-asserted-by":"crossref","first-page":"330","DOI":"10.4236\/jbise.2014.76035","article-title":"Mathematical modelling and simulation of \u03b2-cell mass, insulin and glucose dynamics: Effect of genetic predisposition to diabetes","volume":"7","author":"W Boutayeb","year":"2014","journal-title":"J Biomedical Science and Engineering"},{"key":"pone.0222833.ref013","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1038\/psp.2014.16","article-title":"Effects of il-1\u03b2\u2013blocking therapies in type 2 diabetes mellitus: A quantitative systems pharmacology modeling approach to explore underlying mechanisms","volume":"3","author":"R Palm\u00e9r","year":"2014","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"2","key":"pone.0222833.ref014","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1210\/en.2015-1564","article-title":"A mathematical model of the pathogenesis, prevention, and reversal of type 2 diabetes","volume":"157","author":"J Ha","year":"2016","journal-title":"Endocrinology"},{"key":"pone.0222833.ref015","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJMoa065213","article-title":"Interleukin-1-receptor antagonist in type 2 diabetes mellitus","volume":"356","author":"CM Larsen","year":"2007","journal-title":"N Engl J Med"},{"key":"pone.0222833.ref016","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2337\/dc09-0533","article-title":"Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes","volume":"32","author":"CM Larsen","year":"2009","journal-title":"Diabetes Care"},{"issue":"8","key":"pone.0222833.ref017","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.2337\/dc12-1835","article-title":"Double-blind, randomized study evaluating the glycemic and anti-inflammatory effects of subcutaneous ly2189102, a neutralizing il-1beta antibody, in patients with type 2 diabetes","volume":"36","author":"J Sloan-Lancaster","year":"2013","journal-title":"Diabetes Care"},{"key":"pone.0222833.ref018","first-page":"E200","article-title":"Evaluation of a mathematical model of diabetes progression against observations in the diabetes prevention program","volume":"303","author":"TA Hardy","year":"2012","journal-title":"Am J Physiol"},{"key":"pone.0222833.ref019","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.2337\/diabetes.54.8.2404","article-title":"Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin","volume":"54","author":"AE Kitabchi","year":"2005","journal-title":"Diabetes"},{"key":"pone.0222833.ref020","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"WC Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"pone.0222833.ref021","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.2337\/diabetes.54.4.1150","article-title":"Prevention of type 2 diabetes with troglitazone in the diabetes prevention program","volume":"54","author":"WC Knowler","year":"2005","journal-title":"Diabetes"},{"key":"pone.0222833.ref022","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2337\/diabetes.52.1.102","article-title":"Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes","volume":"52","author":"AE Butler","year":"2003","journal-title":"Diabetes"},{"issue":"1","key":"pone.0222833.ref023","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s125-002-8248-z","article-title":"Reduced beta-cell mass and expression of oxidative stress-related dna damage in the islet of japanese type ii diabetic patients","volume":"45","author":"H Sakuraba","year":"2002","journal-title":"Diabetologia"},{"issue":"5","key":"pone.0222833.ref024","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1210\/jc.2002-020735","article-title":"Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in korea","volume":"88","author":"KH Yoon","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"pone.0222833.ref025","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1210\/jcem-56-3-441","article-title":"The pancreatic polypeptide cells in the human pancreas: the effects of age and diabetes","volume":"56","author":"J Rahier","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"pone.0222833.ref026","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.2337\/diabetes.53.12.3107","article-title":"Islet graft assessment in the edmonton protocol: implications for predicting long-term clinical outcome","volume":"53","author":"CN Street","year":"2004","journal-title":"Diabetes"},{"issue":"9","key":"pone.0222833.ref027","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1369\/jhc.5C6684.2005","article-title":"Assessment of human pancreatic islet architecture and composition by laser scanning confocal microscopy","volume":"53","author":"M Brissova","year":"2005","journal-title":"J Histochem Cytochem"},{"issue":"4","key":"pone.0222833.ref028","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1210\/en.2009-1277","article-title":"\u03b2-cell mass dynamics and islet cell plasticity in human type 2 diabetes","volume":"151","author":"SC Hanley","year":"2010","journal-title":"Endocrinology"},{"issue":"11","key":"pone.0222833.ref029","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1471-0528.1978.tb15835.x","article-title":"A morphological study of the endocrine pancreas in human pregnancy","volume":"85","author":"FA Van Assche","year":"1978","journal-title":"Br J Obstet Gynaecol"},{"key":"pone.0222833.ref030","first-page":"17771","article-title":"Insulin-like growth factor i (igf-i)-stimulated pancreatic beta-cell growth is glucose-dependent","volume":"273","author":"SR Hugl","year":"1998","journal-title":"synergistic activation of insulin receptor substrate-mediated signal transduction pathways by glucose and igf-i in ins-1 cells. J Biol Chem"},{"key":"pone.0222833.ref031","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004827","article-title":"Blood glucose levels regulate pancreatic beta-cell proliferation during experimentally-induced and spontaneous autoimmune diabetes in mice","volume":"4","author":"K Pechhold","year":"2009","journal-title":"PLoS One"},{"key":"pone.0222833.ref032","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.cmet.2011.02.012","article-title":"Control of pancreatic beta cell regeneration by glucose metabolism","volume":"13","author":"S Porat","year":"2011","journal-title":"Cell Metab"},{"key":"pone.0222833.ref033","first-page":"415","article-title":"Glucose toxicity","volume":"13","author":"H Yki-Jarvinen","year":"1992","journal-title":"Endocr Rev"},{"issue":"Suppl 1","key":"pone.0222833.ref034","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1002\/(SICI)1099-0895(199809)14:1+<S45::AID-DMR230>3.3.CO;2-Z","article-title":"Toxicity of hyperglycaemia in type 2 diabetes","volume":"14","author":"H Yki-Jarvinen","year":"1998","journal-title":"Diabetes Metab Rev"},{"issue":"3","key":"pone.0222833.ref035","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00125-004-1336-4","article-title":"Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications","volume":"47","author":"MY Donath","year":"2004","journal-title":"Diabetologia"},{"issue":"3","key":"pone.0222833.ref036","doi-asserted-by":"crossref","first-page":"717","DOI":"10.2337\/diacare.29.03.06.dc05-1538","article-title":"Relationship between beta-cell mass and fasting blood glucose concentration in humans","volume":"29","author":"RA Ritzel","year":"2006","journal-title":"Diabetes Care"},{"key":"pone.0222833.ref037","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.2337\/diabetes.50.8.1683","article-title":"Glucose induces \u03b2-cell apoptosis via upregulation of the Fas receptor in human islets","volume":"50","author":"K Maedler","year":"2001","journal-title":"Diabetes"},{"key":"pone.0222833.ref038","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.2337\/db05-1586","article-title":"Aging correlates with decreased \u03b2-cell proliferative capacity and enhanced sensitivity to apoptosis","volume":"55","author":"K Maedler","year":"2006","journal-title":"Diabetes"},{"key":"pone.0222833.ref039","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1530\/EJE-08-0596","article-title":"Impaired islet turnover in human donor pancreata with aging","volume":"160","author":"C Reers","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"pone.0222833.ref040","doi-asserted-by":"crossref","first-page":"5694","DOI":"10.1210\/endo.137.12.8940401","article-title":"Human pancreatic beta-cell deoxyribonucleic acid-synthesis in islet grafts decreases with increasing organ donor age but increases in response to glucose stimulation in vitro","volume":"137","author":"B Tyrberg","year":"1996","journal-title":"Endocrinology"},{"key":"pone.0222833.ref041","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1210\/jcem.84.3.5542","article-title":"Independent influence of age on basal insulin secretion in nondiabetic humans","volume":"84","author":"P Iozzo","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"pone.0222833.ref042","first-page":"19","article-title":"Insulin and insulin resistance","volume":"26","author":"G Wilcox","year":"2005","journal-title":"Clin Biochem Rev"},{"issue":"5","key":"pone.0222833.ref043","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.2337\/diabetes.48.5.1198","article-title":"Banting lecture 1997. control of glucose uptake and release by the liver in vivo","volume":"48","author":"AD Cherrington","year":"1999","journal-title":"Diabetes"},{"issue":"5","key":"pone.0222833.ref044","first-page":"682","article-title":"Insulin stimulates liver glucose uptake in humans: an 18f-fdg pet study","volume":"44","author":"P Iozzo","year":"2003","journal-title":"J Nucl Med"},{"key":"pone.0222833.ref045","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.2337\/diabetes.53.8.2042","article-title":"Insulin dose-response curves for stimulation of splanchnic glucose uptake and suppression of endogenous glucose production differ in nondiabetic humans and are abnormal in people with type 2 diabetes","volume":"53","author":"R Basu","year":"2004","journal-title":"Diabetes"},{"key":"pone.0222833.ref046","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.2337\/diab.35.12.1326","article-title":"Insulin dose-response characteristics for suppression of glycerol release and conversion to glucose in humans","volume":"35","author":"N Nurjhan","year":"1986","journal-title":"Diabetes"},{"key":"pone.0222833.ref047","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1172\/JCI114142","article-title":"Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus: Evidence for multiple sites of insulin resistance","volume":"84","author":"LC Groop","year":"1989","journal-title":"J Clin Invest"},{"key":"pone.0222833.ref048","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1742-4682-4-35","article-title":"A discrete single delay model for the intra-venous glucose tolerance test","volume":"4","author":"S Panunzi","year":"2007","journal-title":"Theor Biol Med Model"},{"key":"pone.0222833.ref049","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3934\/dcdsb.2007.7.399","article-title":"Qualitative behavior of a family of delay differential models of the glucose insulin system","volume":"7","author":"P Palumbo","year":"2007","journal-title":"Discrete and Continuous Dynamical Systems\u2014Series B"},{"key":"pone.0222833.ref050","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1742-4682-7-9","article-title":"Advantages of the single delay model for the assessment of insulin sensitivity from the intravenous glucose tolerance test","volume":"7","author":"S Panunzi","year":"2010","journal-title":"Theor Biol Med Model"},{"key":"pone.0222833.ref051","doi-asserted-by":"crossref","first-page":"e70875","DOI":"10.1371\/journal.pone.0070875","article-title":"Routine OGTT: A robust model including incretin effect for precise identification of insulin sensitivity and secretion in a single individual","volume":"8","author":"A De Gaetano","year":"2013","journal-title":"PLoS One"},{"key":"pone.0222833.ref052","first-page":"E630","article-title":"Dose-response characteristics for effects of insulin on production and utilization of glucose in man","volume":"240","author":"RA Rizza","year":"1981","journal-title":"Am J Physiol"},{"key":"pone.0222833.ref053","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1210\/jcem-42-5-830","article-title":"Glucagon metabolism in man, studies on the metabolic clearance rate and the plasma acute disappearance time of glucagon in normal and diabetic subjects","volume":"42","author":"FP Alford","year":"1976","journal-title":"J Clin Endocrinol Metab"},{"key":"pone.0222833.ref054","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1073\/pnas.73.5.1735","article-title":"Kinetics of glucagon in man: effects of starvation","volume":"73","author":"M Fisher","year":"1976","journal-title":"Proc Natl Acad Sci USA"},{"key":"pone.0222833.ref055","first-page":"E233","article-title":"Hepatic metabolism of glucagon in the dog: contribution of the liver to overall metabolic disposal of glucagon","volume":"240","author":"JB Jaspan","year":"1981","journal-title":"Am J Physiol"},{"key":"pone.0222833.ref056","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1002577","article-title":"Quantifying the contribution of the liver to glucose homeostasis: a detailed kinetic model of human hepatic glucose metabolism","volume":"8","author":"M Konig","year":"2012","journal-title":"PLoS Comput Biol"},{"key":"pone.0222833.ref057","first-page":"E380","article-title":"Hormonal mechanisms of recovery from insulin-induced hypoglycemia in man","volume":"236","author":"J Gerich","year":"1979","journal-title":"Am J Physiol"},{"key":"pone.0222833.ref058","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/BF00572860","article-title":"Feedback inhibition of insulin and glucagon secretion by insulin is altered in abdominal obesity with normal or impaired glucose tolerance","volume":"30","author":"P Cavallo-Perin","year":"1993","journal-title":"Acta Diabetol"},{"key":"pone.0222833.ref059","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1056\/NEJM198205203062002","article-title":"Feedback inhibition of insulin secretion by insulin: relation to the hyperinsulinemia of obesity","volume":"306","author":"D Elahi","year":"1982","journal-title":"N Engl J Med"},{"key":"pone.0222833.ref060","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.2337\/diacare.26.6.1902","article-title":"Hypoglycemia in diabetes","volume":"26","author":"PE Cryer","year":"2003","journal-title":"Diabetes Care"},{"key":"pone.0222833.ref061","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1126\/science.182.4108.171","article-title":"Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect","volume":"182","author":"JE GGerich","year":"1973","journal-title":"Science"},{"key":"pone.0222833.ref062","doi-asserted-by":"crossref","first-page":"e86963","DOI":"10.1371\/journal.pone.0086963","article-title":"Mathematical modeling of renal tubular glucose absorption after glucose load","volume":"9","author":"A De Gaetano","year":"2014","journal-title":"PLoS One"},{"key":"pone.0222833.ref063","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jcem-73-6-1294","article-title":"Mechanism of metformin actionin obese and lean noninsulin-dependent diabetic subjects","volume":"73","author":"RA DeFronzo","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"pone.0222833.ref064","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1056\/NEJM199508313330903","article-title":"Metabolic effects of metformin in non-insulin-dependent diabetes mellitus","volume":"333","author":"M Stumvoll","year":"1995","journal-title":"N Engl J Med"},{"key":"pone.0222833.ref065","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1056\/NEJM199803263381303","article-title":"Efficacy and metabolic effects of metformin and troglitazone in type ii diabetes mellitus","volume":"338","author":"SE Inzucchi","year":"1998","journal-title":"N Engl J Med"},{"issue":"23","key":"pone.0222833.ref066","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1056\/NEJMoa066224","article-title":"Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy","volume":"355","author":"SE Kahn","year":"2006","journal-title":"N Engl J Med"},{"key":"pone.0222833.ref067","doi-asserted-by":"crossref","first-page":"504","DOI":"10.2337\/diacare.29.03.06.dc05-1937","article-title":"Treatment escalation and rise in hba1c following successful initial metformin therapy","volume":"29","author":"GA Nichols","year":"2006","journal-title":"Diabetes Care"},{"key":"pone.0222833.ref068","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2337\/dc09-1749","article-title":"Secondary failure of metformin monotherapy in clinical practice","volume":"33","author":"JB Brown","year":"2010","journal-title":"Diabetes Care"},{"issue":"64","key":"pone.0222833.ref069","article-title":"On the dependence of the solutions of differential equations on a small parameter","volume":"22","author":"AN Tikhonov","year":"1948","journal-title":"Matimaticheskii Sbornik (NS)"},{"key":"pone.0222833.ref070","unstructured":"Artstein Z (2010) Analysis and control of coupled slow and fast systems: a review. Proceedings of the 9th Brazilian 1254\u20131263."},{"key":"pone.0222833.ref071","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1002\/mana.200410328","article-title":"Two perspectives on reduction of ordinary differential equations","volume":"278","author":"A Zagaris","year":"2005","journal-title":"Math Nachr"},{"key":"pone.0222833.ref072","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mbs.2011.10.003","article-title":"Interaction of fast and slow dynamics in endocrine control systems with an application to beta-cell dynamics","volume":"235","author":"YF Wang","year":"2012","journal-title":"Math Biosci"},{"issue":"10","key":"pone.0222833.ref073","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.2337\/diacare.26.10.2796","article-title":"Low insulin sensitivity (s(i) = 0) in diabetic and nondiabetic subjects in the insulin resistance atherosclerosis study: is it associated with components of the metabolic syndrome and nontraditional risk factors?","volume":"26","author":"SM Haffner","year":"2003","journal-title":"Diabetes Care"},{"issue":"2","key":"pone.0222833.ref074","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s001250051130","article-title":"Fatty acids, lipotoxicity and insulin secretion","volume":"42","author":"JD McGarry","year":"1999","journal-title":"Diabetologia"},{"key":"pone.0222833.ref075","doi-asserted-by":"crossref","first-page":"92","DOI":"10.7326\/0003-4819-133-2-200007180-00008","article-title":"Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men","volume":"133","author":"R Ross","year":"2000","journal-title":"Ann Intern Med"},{"key":"pone.0222833.ref076","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1152\/japplphysiol.00707.2003","article-title":"Effect of the volume and intensity of exercise training on insulin sensitivity","volume":"96","author":"JA Houmard","year":"2004","journal-title":"J Appl Physiol"},{"key":"pone.0222833.ref077","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/jama.279.9.669","article-title":"Intensity and amount of physical activity in relation to insulin sensitivity: the insulin resistance atherosclerosis study","volume":"279","author":"EJ Mayer-Davis","year":"1998","journal-title":"JAMA"},{"issue":"11","key":"pone.0222833.ref078","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1210\/jc.2009-1379","article-title":"Aerobic exercise increases peripheral and hepatic insulin sensitivity in sedentary adolescents","volume":"94","author":"GJ van der Heijden","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"pone.0222833.ref079","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1210\/jc.2007-1524","article-title":"Short-term aerobic exercise training in obese humans with type 2 diabetes mellitus improves whole-body insulin sensitivity through gains in peripheral, not hepatic insulin sensitivity","volume":"93","author":"JJ Winnick","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"pone.0222833.ref080","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2337\/dc11-0925","article-title":"Independent and combined effects of exercise training and metformin on insulin sensitivity in individuals with prediabetes","volume":"35","author":"SK Malin","year":"2012","journal-title":"Diabetes Care"},{"key":"pone.0222833.ref081","doi-asserted-by":"crossref","first-page":"e000059","DOI":"10.1136\/bmjdrc-2014-000059","article-title":"Durability of oral hypoglycemic agents in drug na\u00efve patients with type 2 diabetes: report from the swedish national diabetes register (ndr)","volume":"3","author":"N Ekstr\u00f6m","year":"2015","journal-title":"BMJ Open Diabetes Research and Care"},{"issue":"10","key":"pone.0222833.ref082","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1007\/s00125-010-1809-6","article-title":"Adaptive changes in pancreatic beta cell fractional area and beta cell turnover in human pregnancy","volume":"53","author":"AE Butler","year":"2010","journal-title":"Diabetologia"},{"issue":"22","key":"pone.0222833.ref083","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1001\/jama.2014.5988","article-title":"Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications","volume":"311","author":"L Sj\u00f6str\u00f6m","year":"2014","journal-title":"JAMA"},{"issue":"10","key":"pone.0222833.ref084","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1001\/jamasurg.2015.1534","article-title":"Three-year outcomes of bariatric surgery vs lifestyle intervention for type 2 diabetes mellitus treatment a randomized clinical trial","volume":"150","author":"AP Courcoulas","year":"2015","journal-title":"JAMA Surg"},{"key":"pone.0222833.ref085","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S0140-6736(15)00075-6","article-title":"Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial","volume":"386","author":"G Mingrone","year":"2015","journal-title":"Lancet"},{"key":"pone.0222833.ref086","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/SLA.0000000000000863","article-title":"Predictors of remission of diabetes mellitus in severely obese individuals undergoing bariatric surgery: Do BMI or procedure choice matter? a meta-analysis","volume":"261","author":"S Panunzi","year":"2015","journal-title":"Ann Surg"},{"key":"pone.0222833.ref087","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2337\/dc15-0575","article-title":"Determinants of diabetes remission and glycemic control after bariatric surgery","volume":"39","author":"S Panunzi","year":"2016","journal-title":"Diabetes Care"},{"issue":"4","key":"pone.0222833.ref088","doi-asserted-by":"crossref","first-page":"e0153297","DOI":"10.1371\/journal.pone.0153297","article-title":"A simple, realistic stochastic model of gastric emptying","volume":"11","author":"J Yokrattanasak","year":"2016","journal-title":"PLoS One"},{"key":"pone.0222833.ref089","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0141-5425(92)90058-S","article-title":"A physiological model of glucose-insulin interaction in type 1 diabetes mellitus","volume":"14","author":"ED Lehmann","year":"1992","journal-title":"J Biomed Eng"},{"issue":"8","key":"pone.0222833.ref090","first-page":"1","article-title":"Modeling glucose and free fatty acid kinetics in glucose and meal tolerance test","volume":"13","author":"Y Li","year":"2016","journal-title":"Theor Biol Med Model"},{"issue":"673","key":"pone.0222833.ref091","first-page":"1","article-title":"A minimal model approach for analyzing continuous glucose monitoring in type 2 diabetes","volume":"9","author":"P Goel","year":"2008","journal-title":"Front Physiol"},{"key":"pone.0222833.ref092","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.2337\/db07-0053","article-title":"Progression to type 2 diabetes characterized by moderate then rapid glucose increases","volume":"56","author":"CC Mason","year":"2007","journal-title":"Diabetes"},{"key":"pone.0222833.ref093","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.2337\/dc12-0825","article-title":"Diabetes: Have we got it all wrong?","volume":"35","author":"BE Corkey","year":"2012","journal-title":"Diabetes Care"},{"key":"pone.0222833.ref094","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jtbi.2015.07.033","article-title":"Insulin resistance or hypersecretion? the \u03b2ig picture revisited","volume":"384","author":"P Goel","year":"2015","journal-title":"J Theor Biol"},{"key":"pone.0222833.ref095","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.2337\/diabetes.51.2007.S130","article-title":"Effect of acute hyperglycemia on insulin secretion in humans","volume":"51S1","author":"E Toschi","year":"2002","journal-title":"Diabetes"},{"key":"pone.0222833.ref096","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.2337\/dc11-0046","article-title":"Changes over time in glycemic control, insulin sensitivity, and beta-cell function in response to low-dose metformin and thiazolidinedione combination therapy in patients with impaired glucose tolerance","volume":"34","author":"R Retnakaran","year":"2011","journal-title":"Diabetes Care"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0222833","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,24]],"date-time":"2021-01-24T13:19:46Z","timestamp":1611494386000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0222833"}},"subtitle":[],"editor":[{"given":"Yiqing","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,10,10]]},"references-count":96,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0222833","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,10]]}}}